Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 225 of 2228 entries
View as:

Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)

Phase: N/A Priority: Normal
NCT ID: NCT00654498 Org: User:
Start: 04/30/08 End: 06/30/09 Due: 06/30/10

Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01650259 Org: User:
Start: 07/23/12 End: 09/14/17 Due: 09/14/18

Ambroxol Spray Sore Throat Study

Phase: N/A Priority: Normal
NCT ID: NCT01361802 Org: User:
Start: 05/31/11 End: - Due: -

Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02182050 Org: User:
Start: 08/31/05 End: - Due: -

Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).

Phase: N/A Priority: Normal
NCT ID: NCT00239408 Org: User:
Start: 12/31/02 End: 04/30/04 Due: 04/30/05

Safety, Tolerability, Pharmacokinetics and -Dynamics of Multiple Rising Oral Doses of BI 113823 in Patients Patients With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT01207973 Org: User:
Start: 09/30/10 End: - Due: -

Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00662792 Org: User:
Start: 04/15/08 End: 07/22/09 Due: 07/22/10

A Study in Healthy Men to Test How BI 730357 is Processed by the Body

Phase: N/A Priority: Normal
NCT ID: NCT03664011 Org: User:
Start: 09/10/18 End: 11/13/18 Due: 11/13/19

Safety, Tolerability and Pharmacokinetics After Administration of Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02194322 Org: User:
Start: 11/30/01 End: - Due: -

Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02259985 Org: User:
Start: 03/31/98 End: - Due: -

Ipratropium Bromide in Peri-Operative COPD

Phase: N/A Priority: Normal
NCT ID: NCT01943552 Org: User:
Start: 10/31/13 End: 08/31/15 Due: 08/31/16

Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02223481 Org: User:
Start: 05/31/98 End: - Due: -

Safety, Pharmacokinetics and Pharmacodynamics of BIBR 1048 MS Capsule in Healthy Male Subjects of Japanese and Caucasian Origin

Phase: N/A Priority: Normal
NCT ID: NCT02170909 Org: User:
Start: 12/31/04 End: - Due: -

A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT05065190 Org: User:
Start: 11/25/21 End: 05/07/24 Due: 05/07/25

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT01533922 Org: User:
Start: 03/31/12 End: 11/30/13 Due: 11/30/14

A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT06429137 Org: User:
Start: 07/08/24 End: 05/27/25 Due: 05/27/26

Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT02245529 Org: User:
Start: 03/31/05 End: - Due: -

A Study to Test Different Doses of BI 456906 in Patients With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03591718 Org: User:
Start: 07/26/18 End: 04/30/20 Due: 04/30/21

A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06745284 Org: User:
Start: 03/26/25 End: 06/15/26 Due: 06/15/27

A Study in Healthy Japanese Men to Test How Well Different Doses of BI 764198 Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT04665700 Org: User:
Start: 02/06/21 End: 10/16/21 Due: 10/16/22

Combined Bronchodilators in Chronic Obstructive Pulmonary Disease and the Risk of Adverse Cardio-pulmonary Events

Phase: N/A Priority: Normal
NCT ID: NCT02096731 Org: User:
Start: 03/31/14 End: 08/31/15 Due: 08/31/16

A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS

Phase: N/A Priority: Normal
NCT ID: NCT00349531 Org: User:
Start: 07/31/06 End: - Due: -

A Study in Healthy Men to Test Whether BI 1358894 Reduces Druginduced Panic Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT03904576 Org: User:
Start: 04/18/19 End: 08/29/19 Due: 08/29/20

1-year Clinical Outcomes in Recombinant Tissue Plasminogen Activator (Rt-PA) Treated Chinese Acute Ischaemic Stroke (AIS) Patients

Phase: N/A Priority: Normal
NCT ID: NCT05395338 Org: User:
Start: 04/12/22 End: 11/30/22 Due: 11/30/23

Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02254057 Org: User:
Start: 07/31/02 End: - Due: -